What is NDC 70954-158?

70954-158 is the product NDC for Clorazepate Dipotassium, Clorazepate dipotassium 7.5 mg/1 tablet, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clorazepate Dipotassium?

24 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clorazepate Dipotassium NDC 70954-158 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-158Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0158Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70954-158-10	70954015810	100 TABLET in 1 BOTTLE (70954-158-10)Marketed from Jun 16, 2022
70954-158-20	70954015820	500 TABLET in 1 BOTTLE (70954-158-20)Marketed from Jul 1, 2022
70954-158-30	70954015830	30 TABLET in 1 BOTTLE (70954-158-30)Marketed from Aug 21, 2023
70954-158-50	70954015850	30 BLISTER PACK in 1 BOX, UNIT-DOSE (70954-158-50) / 1 TABLET in 1 BLISTER PACK (70954-158-40)Marketed from Jun 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clorazepate Dipotassium
Generic name (nonproprietary): clorazepate dipotassium
Active ingredients: Clorazepate dipotassium — 7.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213730
Marketing start: Jun 16, 2022
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 70954-158_d4edcb5d-dbe9-44c4-a0a9-d3b6aba4c22dSPL ID d4edcb5d-dbe9-44c4-a0a9-d3b6aba4c22dSPL set ID a4b80e69-b7c7-471a-8ce8-4e992808c669RxCUI 197464, 197465, 197466UNII 63FN7G03XY
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954015810 followed by a unit qualifier and the quantity

Package 70954-0158-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 12, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Clorazepate dipotassium tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. Clorazepate dipotassium tablets are indicated as adjunctive therapy in the management of partial seizures. The effectiveness of clorazepate dipotassium tablets in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. Long-term studies in epileptic patients, however, have shown continued therapeutic activity. The physician should reassess periodically the …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70954-158

What is NDC 70954-158?: 70954-158 is the product NDC for Clorazepate Dipotassium, Clorazepate dipotassium 7.5 mg/1 tablet, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clorazepate Dipotassium.
What is the active ingredient?: Clorazepate dipotassium.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clorazepate Dipotassium?: 24 other product NDCs are listed under this name. See all Clorazepate Dipotassium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clorazepate Dipotassium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clorazepate Dipotassium	Clorazepate dipotassium 7.5 mg/1	TabletOral	Coupler LLC	67046-1601	67046-1601-03
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	Coupler LLC	67046-1462	67046-1462-03
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	Coupler LLC	67046-1501	67046-1501-03
Clorazepate Dipotassium	Clorazepate dipotassium 3.75 mg/1	TabletOral	Aurolife Pharma LLC	13107-282	13107-0282-0113107-0282-05
Clorazepate Dipotassium	Clorazepate dipotassium 7.5 mg/1	TabletOral	Aurolife Pharma LLC	13107-283	13107-0283-0113107-0283-05
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	Aurolife Pharma LLC	13107-284	13107-0284-01
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-157	70954-0157-1070954-0157-2070954-0157-40
Clorazepate Dipotassium	Clorazepate dipotassium 3.75 mg/1	TabletOral	NORTHSTAR RX LLC	72603-112	72603-0112-0172603-0112-02
Clorazepate Dipotassium	Clorazepate dipotassium 7.5 mg/1	TabletOral	NORTHSTAR RX LLC	72603-113	72603-0113-0172603-0113-02
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	NORTHSTAR RX LLC	72603-114	72603-0114-01

All 25 Clorazepate Dipotassium NDCs

Other NDCs under ANDA 213730

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213730
Product	Strength	Form · route	Labeler	Product NDC
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-157
Clorazepate Dipotassium	Clorazepate dipotassium 3.75 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-159
Clorazepate Dipotassium	Clorazepate dipotassium 15 mg/1	TabletOral	Coupler LLC	67046-1462